Advertisement

Leukocyte count is associated with incidence of coronary events, but not with stroke: A prospective cohort study

  • Cairu Li
    Correspondence
    Corresponding author at: Department of Clinical Science, Cardiovascular Epidemiology, Malm University Hospital, Malm s-20502, Sweden. Tel.: +46 46 391327; fax: +46 40 391300.
    Affiliations
    Department of Clinical Sciences, Cardiovascular Epidemiology, Lund University, Malmö University Hospital, Malmö, Sweden
    Search for articles by this author
  • Gunnar Engström
    Affiliations
    Department of Clinical Sciences, Cardiovascular Epidemiology, Lund University, Malmö University Hospital, Malmö, Sweden

    AstraZeneca R&D, Lund, Sweden
    Search for articles by this author
  • Bo Hedblad
    Affiliations
    Department of Clinical Sciences, Cardiovascular Epidemiology, Lund University, Malmö University Hospital, Malmö, Sweden
    Search for articles by this author

      Abstract

      Objective

      Elevated leukocyte count is a classic marker of systemic inflammation. This study examined whether the leukocyte count is associated with incidence of coronary events (CE) and stroke during a long follow-up period.

      Methods

      A total of 17,131 men and 2932 women, aged 27–61 years, without history of cardiovascular disease (CVD), were enrolled. Incidence of CE and stroke was studied in relation to leukocyte concentrations over a mean follow-up of 24 years.

      Results

      During the follow-up period, 2600 CE and 1333 stroke events occurred. After risk factor adjustments, leukocyte concentrations in the highest quartile (vs. lowest, >7.0 vs. <4.7 × 109 cells/L) were associated with CE in men (HR: 1.31, 95%CI: 1.16–1.48, trend p < 0.001), but not significantly in women (HR: 1.46, CI: 0.87–2.46, trend p = 0.13). The increased incidence remained significant after adjustments for plasma fibrinogen in a sub-group of 6018 men (HR: 1.31, CI: 1.08–1.60).
      The association between leukocytes and CE was most pronounced in younger men (aged 27–46) and men without hypertension. In younger men, high leukocytes were associated with early CE (within 10 years of follow-up) and late CE (>10 years of follow-up). In older men (46–61 years), leukocytes were not associated with CE after more than 10 years of follow-up.
      The leukocyte count was not associated with incidence of stroke.

      Conclusion

      Elevated leukocyte count in men is associated with increased incidence of CE, but not with stroke. The increased risk persisted after more than 10 years of follow-up in younger, but not in older men.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Libby P.
        Inflammation in atherosclerosis.
        Nature. 2002; 420: 868-874
        • Hoffman M.
        • Blum A.
        • Baruch R.
        • Kaplan E.
        • Benjamin M.
        Leukocytes and coronary heart disease.
        Atherosclerosis. 2004; 172: 1-6
        • Kannel W.B.
        • Anderson K.
        • Wilson P.W.
        White blood cell count and cardiovascular disease. Insights from the Framingham Study.
        JAMA. 1992; 267: 1253-1256
        • Margolis K.L.
        • Manson J.E.
        • Greenland P.
        • et al.
        Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study.
        Arch Intern Med. 2005; 165: 500-508
        • Madjid M.
        • Awan I.
        • Willerson J.T.
        • Casscells S.W.
        Leukocyte count and coronary heart disease: implications for risk assessment.
        J Am Coll Cardiol. 2004; 44: 1945-1956
        • Lee C.D.
        • Folsom A.R.
        • Nieto F.J.
        • et al.
        White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: Atherosclerosis Risk in Communities Study.
        Am J Epidemiol. 2001; 154: 758-764
        • Elkind M.S.
        • Sciacca R.R.
        • Boden-Albala B.
        • et al.
        Relative elevation in baseline leukocyte count predicts first cerebral infarction.
        Neurology. 2005; 64: 2121-2125
        • Danesh J.
        • Wheeler J.G.
        • Hirschfield G.M.
        • et al.
        C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.
        N Engl J Med. 2004; 350: 1387-1397
        • Sebastián-Gámbaro M.A.
        • Lirón-Hernández F.J.
        • Fuentes-Arderiu X.
        Intra- and inter-individual biological variability data bank.
        Eur J Clin Chem Clin Biochem. 1997; 35: 845-852
        • Pankow J.S.
        • Folsom A.R.
        • Cushman M.
        • et al.
        Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study.
        Atherosclerosis. 2001; 154: 681-689
        • Jenny N.S.
        • Yanez N.D.
        • Psaty B.M.
        • et al.
        Inflammation biomarkers and near-term death in older men.
        Am J Epidemiol. 2007; 165: 684-695
        • Pirro M.
        • Bergeron J.
        • Dagenais G.R.
        • et al.
        Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men.
        Arch Intern Med. 2001; 16: 2474-2480
        • Berglund G.
        • Eriksson K.F.
        • Israelsson B.
        • et al.
        Cardiovascular risk groups and mortality in an urban Swedish male population.
        J Intern Med. 1996; 239: 489-497
        • Lind P.
        • Engström G.
        • Stavenow L.
        • et al.
        Risk of myocardial infarction and stroke in smokers is related to plasma levels of inflammation-sensitive proteins.
        Arterioscler Thromb Vasc Biol. 2004; 24: 577-582
        • Kristenson H.
        • Trell E.
        Indicators of alcohol consumption: comparisons between a questionnaire (Mm-MAST), interviews and serum gamma-glutamyl transferase (GGT) in a health survey of middle-aged males.
        Br J Addict. 1982; 77: 297-304
      1. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413–46.

        • De Backer G.
        • Ambrosioni E.
        • Borch-Johnsen K.
        • et al.
        European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts).
        Atherosclerosis. 2004; 173: 381-391
        • Engström G.
        • Stavenow L.
        • Hedblad B.
        • et al.
        Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study.
        Diabetes. 2003; 52: 442-447
        • Laurell C.B.
        Electroimmuno assay.
        Scand J Clin Lab Invest. 1972; : 21-37
      2. The National board of Health and Welfare. Värdering av diagnoskvaliteten för akut hjärtinfarkt i patientregistret 1997 och 1995 (in Swedish). Stockholm, Sweden: Socialstyrelsen; 2000.

        • Jerntorp P.
        • Berglund G.
        Stroke registry in Malmö.
        Stroke. 1992; 23: 357-361
        • Schillaci G.
        • Pirro M.
        • Pucci G.
        • et al.
        Prognostic value of elevated white blood cell count in hypertension.
        Am J Hypertens. 2007; 20: 364-369
        • Wilhelmsen L.
        • Köster M.
        • Harmsen P.
        • Lappas G.
        Differences between coronary disease and stroke in incidence, case fatality, and risk factors, but few differences in risk factors for fatal and non-fatal events.
        Eur Heart J. 2005; 26: 1916-1922
        • Gillum R.F.
        • Ingram D.D.
        • Makuc D.M.
        White blood cell count and stroke incidence and death. The NHANES I epidemiologic follow-up study.
        Am J Epidemiol. 1994; 139: 894-902
        • Rana J.S.
        • Boekholdt S.M.
        • Ridker P.M.
        • et al.
        Differential leukocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC-Norfolk Prospective Population Study.
        J Intern Med. 2007; 262: 678-689